FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jordi Puig

Research Profile

Disorders

Chemicals & Drugs

Procedures

Living Beings

HIV-1

Concepts & Ideas

Anatomy

Physiology

Virus Replication

Co-author Network

Publications

TOP 3
Anna Bonjoch; Maria Casadellà; Bonaventura Clotet; Eugenia Negredo; Marc Noguera-Julian; Núria Pérez-Álvarez; Christian Pou; Jordi Puig; Rocío Bellido; Roger Paredes
Switching the third drug of antiretroviral therapy to maraviroc in aviraemic subjects: a pilot, prospective, randomized clinical trial.
Marta Massanella; Eugenia Negredo; Núria Pérez-Álvarez; Maria Carmen Puertas; Jordi Puig; Maria J Buzón; Jorge Carrillo; Bonaventura Clotet; Javier Martínez-Picado; Julià Blanco
Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery.
Anna Bonjoch; Bonaventura Clotet; Patricia Echeverría; Carla Estany; Núria Perez-Alvarez; Jordi Puig; Eugenia Negredo
High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jordi Puig (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anna Bonjoch; Maria Casadellà; Bonaventura Clotet; Eugenia Negredo; Marc Noguera-Julian; Núria Pérez-Álvarez; Christian Pou; Jordi Puig; Rocío Bellido; Roger Paredes
Switching the third drug of antiretroviral therapy to maraviroc in aviraemic subjects: a pilot, prospective, randomized clinical trial.
The Journal of antimicrobial chemotherapy 2013;68(6):1382-7.
2012: Marta Massanella; Eugenia Negredo; Núria Pérez-Álvarez; Maria Carmen Puertas; Jordi Puig; Maria J Buzón; Jorge Carrillo; Bonaventura Clotet; Javier Martínez-Picado; Julià Blanco
Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery.
AIDS (London, England) 2012;26(18):2285-93.
2012: Anna Bonjoch; Bonaventura Clotet; Patricia Echeverría; Carla Estany; Núria Perez-Alvarez; Jordi Puig; Eugenia Negredo
High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy.
Antiviral research 2012;96(1):65-9.
2012: Mireia Miquel; Jordi Puig; Jorge Sánchez-Delgado; Julia Sopeña; Mercedes Vergara; Anna Alguersuari; Meritxell Casas; Eva Criado; Montserrat Gil; Blai Dalmau
Factors related to survival in hepatocellular carcinoma in the geographic area of Sabadell (Catalonia, Spain).
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2012;104(5):242-7.
2012: Carmina R Fumaz; Marian Gonzalez-Garcia; Anuska Llano; Beatriz Mothe; Jose Munoz-Moreno; Nuria Perez-Alvarez; Jordi Puig; Xavier Borras; Christian Brander; Jordi Fernandez-Castro; Maria José Ferrer; Bonaventura Clotet
Psychological stress is associated with high levels of IL-6 in HIV-1 infected individuals on effective combined antiretroviral treatment.
Brain, behavior, and immunity 2012;26(4):568-72.
2012: Eugenia Negredo; Nuria Perez-Alvarez; Jordi Puig; Joaquin Rosales; Luís del Rio; Silvana di Gregorio; Carla Estany; Guadalupe Gómez; Moisés Gómez-Mateu; Anna Bonjoch; Bonaventura Clotet
Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan.
PloS one 2012;7(10):e46031.
2010: Echeverria Patricia; Pere Domingo; Mar Gutierrez; Mateo Gracia; Monse Fuster; José Molto; Jordi Puig; Nuria Perez-Alvarez; Bonaventura Clotet; Eugenia Negredo
Saquinavir/ritonavir monotherapy as a new nucleoside-sparing maintenance strategy in long-term virologically suppressed HIV-infected patients.
Current HIV research 2010;8(6):467-70.
2010: Eugenia Negredo; Joan Romeu; Benjamí Rodríguez-Santiago; Oscar Miró; Glòria Garrabou; Jordi Puig; Núria Pérez-Alvarez; Constanza Moren; Lidia Ruiz; Rocio Bellido; Cristina Miranda; Bonaventura Clotet
Mild improvement in mitochondrial function after a 3-year antiretroviral treatment interruption despite persistent impairment of mitochondrial DNA content.
Current HIV research 2010;8(5):379-85.
2010: Eugenia Negredo; Marta Massanella; Jordi Puig; Núria Pérez-Alvarez; José Miguel Gallego-Escuredo; Joan Villarroya; Francesc Villarroya; José Moltó; José Ramón Santos; Bonaventura Clotet; Julià Blanco
Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(9):1300-8.
2010: Marta Massanella; Eugenia Negredo; Núria Pérez-Alvarez; Jordi Puig; Raul Ruiz-Hernández; Margarita Bofill; Bonaventura Clotet; Julià Blanco
CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART.
AIDS (London, England) 2010;24(7):959-68.
2010: Maria José Buzón; Judith Dalmau; Maria Carmen Puertas; Jordi Puig; Bonaventura Clotet; Javier Martinez-Picado
The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates.
AIDS (London, England) 2010;24(1):17-25.
2009: Carmina R Fumaz; Marian Gonzalez-Garcia; Xavier Borras; Maria José Ferrer; Jose Munoz-Moreno; Ruth Peña; Nuria Perez-Alvarez; Jordi Puig; Roger Paredes; Jordi Fernandez-Castro; Bonaventura Clotet
Increased peripheral proinflammatory cytokines in HIV-1-infected patients with prolonged viral suppression suffering from high psychological stress.
Journal of acquired immune deficiency syndromes (1999) 2009;52(3):427-8.
2009: Eugenia Negredo; Jordi Puig; David Aldea; Manuel Medina; Carla Estany; Núria Pérez-Alvarez; Carmina Rodríguez-Fumaz; Jose Munoz-Moreno; Carmen Higueras; Vicente Gonzalez-Mestre; Bonaventura Clotet
Four-year safety with polyacrylamide hydrogel to correct antiretroviral-related facial lipoatrophy.
AIDS research and human retroviruses 2009;25(4):451-5.
2008: Eugenia Negredo; Isabel Puigdomènech; Silvia Marfil; Jordi Puig; Núria Pérez-Alvarez; Lidia Ruiz; Celestino Rey-Joly; Bonaventura Clotet; Julià Blanco
Association between HIV replication and cholesterol in peripheral blood mononuclear cells in HIV-infected patients interrupting HAART.
The Journal of antimicrobial chemotherapy 2008;61(2):400-4.
2008: Eugènia Negredo; Glòria Garrabou; Jordi Puig; Sònia Lòpez; Constanza Morén; Rocio Bellido; Rafaela Ayen; Francesc Cardellach; Oscar Miró; Bonaventura Clotet
Partial immunological and mitochondrial recovery after reducing didanosine doses in patients on didanosine and tenofovir-based regimens.
Antiviral therapy 2008;13(2):231-40.
2007: José Moltó; Asunción Blanco; Cristina Miranda; José Miranda; Jordi Puig; Marta Valle; Meritxell DelaVarga; Carmina R Fumaz; Manel J Barbanoj; Bonaventura Clotet
Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice.
British journal of clinical pharmacology 2007;63(6):715-21.
2006: Eugenia Negredo; Carmen Higueras; Xavier Adell; Juan Carlos Martinez; Eva Martinez; Jordi Puig; Carmina R Fumaz; Jose Munoz-Moreno; Nuria Perez-Alvarez; Sebastián Videla; Carla Estany; Denise Cinquegrana; Vicente Gonzalez-Mestre; Bonaventura Clotet
Reconstructive treatment for antiretroviral-associated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances.
AIDS patient care and STDs 2006;20(12):829-37.
2006: Eugenia Negredo; José Moltó; Jordi Puig; Denise Cinquegrana; Anna Bonjoch; Núria Pérez-Alvarez; Raquel López-Blázquez; Asunción Blanco; Bonaventura Clotet; Celestino Rey-Joly
Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins.
AIDS (London, England) 2006;20(17):2159-64.
2006: José Moltó; Asunción Blanco; Cristina Miranda; José Miranda; Jordi Puig; Marta Valle; Meritxell DelaVarga; Carmina R Fumaz; Manel J Barbanoj; Bonaventura Clotet
Variability in non-nucleoside reverse transcriptase and protease inhibitor concentrations among HIV-infected adults in routine clinical practice.
British journal of clinical pharmacology 2006;62(5):560-6.
2006: Anna Bonjoch; Eugenia Negredo; Jordi Puig; Itziar Erkizia; Teresa Puig; Cecilia Cabrera; Lidia Ruiz; Bonaventura Clotet
Viral failure in HIV-infected patients with long-lasting viral suppression who discontinued enfuvirtide.
AIDS (London, England) 2006;20(14):1896-8.
2006: Anna Bonjoch; Roger Paredes; Pere Domingo; Manel Cervantes; Enric Pedrol; Esteban Ribera; Lluís Force; Josep M Llibre; Josep Vilaró; David Dalmau; Josep Cucurull; Jaume Mascaró; Angels Masabeu; Núria Pérez-Alvarez; Jordi Puig; Denise Cinquegrana; Bonaventura Clotet
Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients.
AIDS research and human retroviruses 2006;22(4):321-9.
2006: Eugenia Negredo; Bonaventura Clotet; Jordi Puig; Núria Pérez-Alvarez; Lidia Ruiz; Joan Romeu; José Moltó; Celestino Rey-Joly; Julià Blanco
The effect of atorvastatin treatment on HIV-1-infected patients interrupting antiretroviral therapy.
AIDS (London, England) 2006;20(4):619-21.
2005: Eugenia Negredo; Anna Bonjoch; Roger Paredes; Jordi Puig; Bonaventura Clotet
Compromised immunologic recovery in treatment-experienced patients with HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studies.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(6):901-5.
2005: Alain Pruvost; Eugenia Negredo; Henri BENECH; Frédéric Theodoro; Jordi Puig; Eulàlia Grau; Elisabet García; José Moltó; Jacques Grassi; Bonaventura Clotet
Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients.
Antimicrobial agents and chemotherapy 2005;49(5):1907-14.
2005: Eugenia Negredo; José Moltó; David Burger; Helene Côté; Oscar Miró; Josep Ribalta; Eva Martínez; Jordi Puig; Lidia Ruiz; Juliana Salazar; Sònia López; Julio Montaner; Celestino Rey-Joly; Bonaventura Clotet
Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study).
Journal of acquired immune deficiency syndromes (1999) 2005;38(1):47-52.
2004: Eugenia Negredo; José Moltó; Jose Munoz-Moreno; Enric Pedrol; Esteban Ribera; Pompeyo E. Viciana; M José Galindos; Celia Miralles; David Burger; Carmina Rodriguez Fumaz; Jordi Puig; Silvia Gel; Eva Rodríguez; Sebastián Videla; Lidia Ruiz; Bonaventura Clotet
Safety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approach.
Antiviral therapy 2004;9(3):335-42.
2004: Eugenia Negredo; José Moltó; David Burger; Pompeyo E. Viciana; Esteban Ribera; Roger Paredes; Manel Juan; Lidia Ruiz; Jordi Puig; Alain Pruvost; Jacques Grassi; Elisabeth Masmitjà; Bonaventura Clotet
Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load.
AIDS (London, England) 2004;18(3):459-63.
2002: Natalia Garcia-Giralt; Xavier Nogués; Anna Enjuanes; Jordi Puig; Leonardo Mellibovsky; Anne-Christine Bay-Jensen; Ramon Carreras; Susana Balcells; Adolfo Díez-Pérez; Daniel Grinberg
Two new single-nucleotide polymorphisms in the COL1A1 upstream regulatory region and their relationship to bone mineral density.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17(3):384-93.
1997: Adolfo Diez; Sergi Serrano; J Cucurull; L Mariñoso; J Bosch; Jordi Puig; Xavier Nogués; J Aubia
Acute effects of ethanol on mineral metabolism and trabecular bone in Sprague-Dawley rats.
Calcified tissue international 1997;61(2):168-71.